TCF21 and coronary artery disorder: Vascular smooth muscle cell expression quantitative trait locus (eQTL) studies [19], as well mechanistic follow-up studies, have identified TCF21 as the causal gene in the CAD-associated locus at 6q23.2 [20] and suggested that expression of this gene is protective toward CAD risk [21].